These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20952210)

  • 1. Expression of extra domain A containing fibronectin in chronic cardiac allograft rejection.
    Franz M; Berndt A; Grün K; Richter P; Kosmehl H; Neri D; Gummert J; Figulla HR; Brehm BR; Renner A
    J Heart Lung Transplant; 2011 Jan; 30(1):86-94. PubMed ID: 20952210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra cellular matrix remodelling after heterotopic rat heart transplantation: gene expression profiling and involvement of ED-A+ fibronectin, alpha-smooth muscle actin and B+ tenascin-C in chronic cardiac allograft rejection.
    Franz M; Grün K; Richter P; Brehm BR; Fritzenwanger M; Hekmat K; Neri D; Gummert J; Figulla HR; Kosmehl H; Berndt A; Renner A
    Histochem Cell Biol; 2010 Nov; 134(5):503-17. PubMed ID: 20931338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy.
    Siddiqui I; Khan ZA; Lian D; Jiang J; Zhong R; Garcia B; Chakrabarti S
    Transplantation; 2006 Aug; 82(3):406-14. PubMed ID: 16906041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective imaging of chronic cardiac rejection using a human antibody specific to the alternatively spliced EDA domain of fibronectin.
    Franz M; Hilger I; Grün K; Kossatz S; Richter P; Petersen I; Jung C; Gummert J; Figulla HR; Kosmehl H; Neri D; Berndt A; Renner A
    J Heart Lung Transplant; 2013 Jun; 32(6):641-50. PubMed ID: 23701854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of interleukin-10 to chronic cardiac allograft rejection using a human antibody specific to the extra domain A of fibronectin.
    Franz M; Doll F; Grün K; Richter P; Köse N; Ziffels B; Schubert H; Figulla HR; Jung C; Gummert J; Renner A; Neri D; Berndt A
    Int J Cardiol; 2015 Sep; 195():311-22. PubMed ID: 26056964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of endothelin-1 mRNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis.
    Watschinger B; Sayegh MH; Hancock WW; Russell ME
    Am J Pathol; 1995 May; 146(5):1065-72. PubMed ID: 7747801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microarray-based gene expression profiling of retransplanted rat cardiac allografts that develop cardiac allograft vasculopathy.
    Kitagawa-Sakakida S; Fukushima N; Sawa Y; Horiguchi K; Doi T; Shirakura R; Matsuda H
    J Heart Lung Transplant; 2005 Dec; 24(12):2068-74. PubMed ID: 16364851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of platelet-derived growth factor ligands in rat cardiac allograft vasculopathy and fibrosis.
    Tuuminen R; Nykänen A; Keränen MA; Krebs R; Alitalo K; Koskinen PK; Lemström KB
    Transplant Proc; 2006 Dec; 38(10):3271-3. PubMed ID: 17175246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats.
    Coito AJ; Binder J; Brown LF; de Sousa M; Van de Water L; Kupiec-Weglinski JW
    J Immunol; 1995 Mar; 154(6):2949-58. PubMed ID: 7876561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for recipient derived fibroblast recruitment and activation during the development of chronic cardiac allograft rejection.
    Wu GD; Tuan TL; Bowdish ME; Jin YS; Starnes VA; Cramer DV; Barr ML
    Transplantation; 2003 Aug; 76(3):609-14. PubMed ID: 12923453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDGF-A, -C, and -D but not PDGF-B increase TGF-beta1 and chronic rejection in rat cardiac allografts.
    Tuuminen R; Nykänen AI; Krebs R; Soronen J; Pajusola K; Keränen MA; Koskinen PK; Alitalo K; Lemström KB
    Arterioscler Thromb Vasc Biol; 2009 May; 29(5):691-8. PubMed ID: 19213942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cadherin expression in cardiac allograft vasculopathy: bench to bedside translational investigation.
    Collot-Teixeira S; McGregor JL; Morser K; Chalabreysse L; McDermott-Roe C; Cerutti C; Guzman A; Michel JB; Boissonnat P; Sebbag L; Thivolet-Bejui F; Bricca G; Obadia JF; Roussoulières A
    J Heart Lung Transplant; 2010 Jul; 29(7):792-9. PubMed ID: 20456977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of the apoptosis-related inflammasome in cardiac allograft rejection.
    Seto T; Kamijo S; Wada Y; Yamaura K; Takahashi K; Komatsu K; Otsu Y; Terasaki T; Fukui D; Amano J; Taniguchi S; Sagara J; Ito K
    J Heart Lung Transplant; 2010 Mar; 29(3):352-9. PubMed ID: 20036165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolongation of rat cardiac allograft survival by a monoclonal antibody: anti-rat intercellular adhesion molecule-1.
    Kobayashi H; Miyano T; Yamataka A; Yamataka T; Yagita H; Eto H; Ligo Y; Tansyo S; Kojima Y; Tamatani T
    Cardiovasc Surg; 1993 Oct; 1(5):577-82. PubMed ID: 7915626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy.
    Yamaura K; Ito K; Tsukioka K; Wada Y; Makiuchi A; Sakaguchi M; Akashima T; Fujimori M; Sawa Y; Morishita R; Matsumoto K; Nakamura T; Suzuki J; Amano J; Isobe M
    Circulation; 2004 Sep; 110(12):1650-7. PubMed ID: 15364799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications.
    Khanna AK; Plummer MS; Hilton G; Pieper GM; Ledbetter S
    Circulation; 2004 Dec; 110(25):3822-9. PubMed ID: 15583082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of vascular smooth muscle alpha-actin on cardiac allograft vasculopathy and fibrosis].
    Zhang M; Yang J; Hu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Apr; 34(4):323-6. PubMed ID: 19411749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common protective and diverse smooth muscle cell effects of AAV-mediated angiopoietin-1 and -2 expression in rat cardiac allograft vasculopathy.
    Nykänen AI; Pajusola K; Krebs R; Keränen MA; Raisky O; Koskinen PK; Alitalo K; Lemström KB
    Circ Res; 2006 Jun; 98(11):1373-80. PubMed ID: 16690881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sinomenine blocks tissue remodeling in a rat model of chronic cardiac allograft rejection.
    Mark W; Schneeberger S; Seiler R; Stroka DM; Amberger A; Offner F; Candinas D; Margreiter R
    Transplantation; 2003 Apr; 75(7):940-5. PubMed ID: 12698077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.